Slides on Medical Minute 3: Clinical Trial Results for GIP/GLP-1 Coagonists

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on emerging data on tirzepatide for type 2 diabetes

Carol Hatch Wysham, MD Released: September 21, 2021

This is the snippet that appears below the blue link in Google search. Words that matched the user query get pulled out in bold. From Clinical Care Options (CCO) and Dr. Ananda Basu, a brief commentary on barriers to use of diabetes technology

Ananda Basu, MD, FRCP Released: September 15, 2021

Short video from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s) Released: September 2, 2021 Expired: September 1, 2022

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on the role of obesity in the pathogenesis of type 2 diabetes

Carol Hatch Wysham, MD Released: September 2, 2021